核医学在儿童心脏病学中的应用
本文综述核医学在儿童先天性心脏病(CHD)管理中的作用。核医学可无创定量肺血流对称性和右向左分流,SPECT/CT与PET/CT等混合设备及新重建算法显著降低注射剂量与辐射暴露;18FDG PET/CT在儿童血管炎、疑似瓣膜感染或感染性人工装置评估中的应用增多。
要点
- 核医学可定量CHD的肺血流对称性与右向左分流,是超声心动图的理想补充。
- SPECT/CT和PET/CT混合设备及新重建算法可显著降低注射剂量与辐射暴露。
- 18FDG PET/CT在儿童血管炎、疑似瓣膜感染或感染性人工装置评估中的应用增多。
核心结论
- 核医学以安全、可重复的方式在组织水平探索CHD的多种功能方面,是超声心动图的理想补充。
- PET/MR和新型放射性药物(如用于心肌灌注的氟化化合物)为儿童心脏病学核医学应用开辟新前景。
研究设计与样本
- 综述,未报告系统检索范围。
主要发现
- 核医学可定量肺血流对称性或右向左分流。
- SPECT/CT与PET/CT混合设备、改进的探测器和新的重建算法可显著降低注射剂量,并相应减少辐射暴露。
- 18FDG PET/CT在儿童血管炎、疑似瓣膜感染或感染性人工装置评估中的研究增多。
临床怎么用
- 核医学无创、镇静需求有限、辐射负担低且不受体型变化影响,是超声心动图的理想补充。
- 在CHD患者随访中,核医学的补充作用尤为明显。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate cardiovascular imaging is essential for the successful management of patients with congenital heart disease (CHD). Echocardiography and angiography have been for long time the most important imaging modalities in pediatric cardiology, but nuclear medicine has contributed in many situations to the comprehension of physiological consequences of CHD, quantifying pulmonary blood flow symmetry or right-to-left shunting. In recent times, remarkable improvements in imaging equipments, particularly in multidetector computed tomography and magnetic resonance imaging, have led to the progressive integration of high resolution modalities in the clinical workup of children affected by CHD, reducing the role of diagnostic angiography. Technology has seen a parallel evolution in the field of nuclear medicine, with the advent of hybrid machines, as SPECT/CT and PET/CT scanners. Improved detectors, hugely increased computing power, and new reconstruction algorithms allow for a significant reduction of the injected dose, with a parallel relevant decrease in radiation exposure. Nuclear medicine retains its distinctive capability of exploring at the tissue level many functional aspects of CHD in a safe and reproducible way. The lack of invasiveness, the limited need for sedation, the low radiation burden, and the insensitivity to body habitus variations make nuclear medicine an ideal complement of echocardiography. This is particularly true during the follow-up of patients with CHD, whose increasing survival represent a great medical success and a challenge for the health system in the next decades. Metabolic imaging using 18FDG PET/CT has expanded its role in the management of infection and inflammation in adult patients, particularly in cardiology. The same expansion is observed in pediatric cardiology, with an increasing rate of studies on the use of FDG PET for the evaluation of children with vasculitis, suspected valvular infection or infected prosthetic devices. The introduction in the clinical practice of the first integrated PET/MR scanners and the development of new radiopharmaceuticals, as fluorinated compounds for the study of myocardial perfusion, open new perspectives in the use of nuclear medicine techniques in pediatric cardiology, offering the potential of a detailed noninvasive morphofunctional characterization in many types of CHD.
引用
- Milanesi O, Stellin G, Zucchetta P, et al. Nuclear Medicine in Pediatric Cardiology. Semin Nucl Med. 2017. PMID: 28237004. doi:10.1053/j.semnuclmed.2016.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。